{"id":212139,"name":"ENALARE THERAPEUTICS, INC.","slug":"enalare-therapeutics-inc","state":"NJ","country":"United States of America","description":"Biopharmaceutical company","totalSpending":10000,"filings":8,"yearlySpending":[{"year":2021,"income":0},{"year":2022,"income":10000},{"year":2023,"income":0}],"issues":[{"code":"DEF","display":"Defense"}],"firms":["AMERICAN DEFENSE INTERNATIONAL, INC."],"lobbyists":["VAN HIPP"],"govEntities":["Defense, Dept of (DOD)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Discussion of DoD funding of drug therapy research","Meetings with officials regarding the relevance of respiratory stimulants to the DOD.","National Defense Authorization Act for FY23, provisions relating to the relevance of respiratory stimulants to the DOD.","HR 7900 National Defene Authorization Act for FY23, proviion relating to respiratory stimulants.","HR 7900 National Defense Authorization Act for FY23, provision relating to respiratory stimulants."]}